Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim ; volume:24 ; number:2 ; day:3 ; month:7 ; year:2024 ; pages:285-301 ; date:6.2024
Drugs in R & D ; 24, Heft 2 (3.7.2024), 285-301, 6.2024
- Creator
-
Kuehne, Henriette
Davis, Janice M.
Merewether, LeeAnne
McQueen, Matthew
Valentine, Elizabeth
Young, Glen
Andrews, Benjamin T.
Diaz, Dimitri
Miller, Karen J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-024-00471-9
- URN
-
urn:nbn:de:101:1-2410291025487.776652103259
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuehne, Henriette
- Davis, Janice M.
- Merewether, LeeAnne
- McQueen, Matthew
- Valentine, Elizabeth
- Young, Glen
- Andrews, Benjamin T.
- Diaz, Dimitri
- Miller, Karen J.
- SpringerLink (Online service)
Other Objects (12)
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Correction to: Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference Tocilizumab
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product